Filing Details
- Accession Number:
- 0001140361-15-041266
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-11-13 19:18:28
- Reporting Period:
- 2015-11-11
- Filing Date:
- 2015-11-13
- Accepted Time:
- 2015-11-13 19:18:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1428336 | Healthequity Inc | HQY | Services-Business Services, Nec (7389) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1623681 | Matthew Sydney | C/O Healthequity, Inc. 15 W. Scenic Pointe Dr., Ste. 100 Draper UT 84020 | Exec Vp, Sales & Marketing | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-11-11 | 35,000 | $35.00 | 100 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | $0.80 | 2021-04-29 | 5,000 | 5,000 | Direct | |
Common Stock | Stock Option (right to buy) | $20.80 | 2024-11-01 | 50,000 | 50,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2021-04-29 | 5,000 | 5,000 | Direct |
2024-11-01 | 50,000 | 50,000 | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 10, 2015.
- The options became exercisable in annual installments of 1,250 shares on April 29 in each of the years 2012, 2013, 2014 and 2015.
- The options became exercisable as to 12,500 shares on November 1, 2015, and become exercisable as to the remaining 37,5000 shares in three annual installments of 12,500 on November 1 2016, 2017 and 2018.